Expression of glypican-3, a new marker of hepatocellular carcinoma, in non-hepatic human malignant tumors

被引：0
|
作者：
Jia, Angela Y.
Hwang, Queena Y.
Allegretta, Mark
Guttmann, Ronald
Jothy, Serge
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] BioMosaics Inc, Burlington, VT USA
[3] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
来源：
MODERN PATHOLOGY | 2006年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
565
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [41] Diffuse and canalicular patterns of glypican-3 expression reflect malignancy of hepatocellular carcinoma
    Kawaida, Miho
    Yamazaki, Ken
    Tsujikawa, Hanako
    Fukuma, Mariko
    Abe, Yuta
    Kitago, Minoru
    Shinoda, Masahiro
    Kitagawa, Yuko
    Sakamoto, Michiie
    PATHOLOGY INTERNATIONAL, 2019, 69 (03) : 125 - 134
  • [42] Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma
    Allegretta, Mark
    Filmus, Jorge
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2011, 11 (06) : 543 - 548
  • [43] Gene Expression of Hepatocellular Carcinoma Reveals Glypican-3 Role as Potential Biomarker
    Nastase, Anca
    Bacalbasa, Nicolae
    Ilie, Veronica
    Florea, Raluca
    Sorop, Andrei
    Tica, Valeria
    Paslaru, Liliana
    Iacob, Razvan
    Grigorie, Razvan
    Herlea, Vlad
    Dima, Simona
    Popescu, Irinel
    ROMANIAN BIOTECHNOLOGICAL LETTERS, 2014, 19 (05): : 9657 - 9665
  • [44] Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
    Li Wang
    Min Yao
    Liu-Hong Pan
    Qi Qian
    Deng-Fu Yao
    Hepatobiliary&PancreaticDiseasesInternational, 2015, 14 (04) : 361 - 366
  • [45] Glypican-3 and Alphafetoprotein as Diagnostic Tests for Hepatocellular Carcinoma
    Jorge Filmus
    Mariana Capurro
    Molecular Diagnosis, 2004, 8 (4) : 207 - 212
  • [46] Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
    Wang, Li
    Yao, Min
    Pan, Liu-Hong
    Qian, Qi
    Yao, Deng-Fu
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (04) : 361 - 366
  • [47] Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions
    Wang, H. L.
    Zhai, J.
    Adley, B.
    Anatelli, F.
    Chuang, S. T.
    Yang, X. J.
    LABORATORY INVESTIGATION, 2007, 87 : 295A - 295A
  • [48] Prognostic significance of glypican-3 expression in hepatocellular carcinoma A meta-analysis
    Liu, Hong
    Yang, Chunmei
    Lu, Wenzhu
    Zeng, Yong
    MEDICINE, 2018, 97 (04)
  • [49] DEVELOPMENT AND VALIDATION OF AN SCFV SPECIFIC FOR HUMAN GLYPICAN-3 FOR THERAPY OF HEPATOCELLULAR CARCINOMA
    Li, Yonghai
    Zhao, Aizhi
    Li, Hong
    Adeyemo, Oluwasayo
    Elkin, Daniel
    Scholler, Nathalie
    Kaplan, David E.
    HEPATOLOGY, 2009, 50 (04) : 1135A - 1135A
  • [50] Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma
    Li, Li
    Jin, Ronghua
    Zhang, Xiaoli
    Lv, Fudong
    Liu, Lifeng
    Liu, Daojie
    Liu, Kai
    Li, Ning
    Chen, Dexi
    HEPATOLOGY, 2012, 56 (04) : 1380 - 1390
12345